Overview

Clinical Trial of Efficacy and Safety of Subetta in the Combined Treatment of Patients With Type II Diabetes Mellitus

Status:
Completed
Trial end date:
2016-06-15
Target enrollment:
Participant gender:
Summary
The purpose of this study is: - to assess clinical efficacy of Subetta in the combined treatment of type II diabetes mellitus; - to assess safety of Subetta in the combined treatment of type II diabetes mellitus.
Phase:
Phase 4
Details
Lead Sponsor:
Materia Medica Holding